Positron Corporation (POSC)

OTCMKTS · Delayed Price · Currency is USD
2.499
+0.059 (2.40%)
At close: Feb 27, 2026
32.20%
Market Cap 82.07M
Revenue (ttm) 486.45K
Net Income (ttm) -4.83M
Shares Out 32.85M
EPS (ttm) -0.16
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 39,255
Average Volume 196,503
Open 2.460
Previous Close 2.440
Day's Range 2.330 - 2.620
52-Week Range 1.220 - 2.740
Beta 0.75
RSI 64.39
Earnings Date Mar 31, 2026

About Positron

Positron Corporation develops, manufactures, and sells cardiac positron emission tomography imaging systems in the United States. The company offers Attrius PET and NeuSight PET-CT 64-slice used in non-invasive diagnosis and evaluation of coronary artery disease and supports various molecular imaging applications, including cardiology, oncology, and neurology. It also provides clinical and technical support services, such as physician interpretation training, nurse and technologist training, billing and prior-authorization assistance, physician... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1983
Employees 10
Stock Exchange OTCMKTS
Ticker Symbol POSC
Full Company Profile

Financial Performance

In 2024, Positron's revenue was $587,500, a decrease of -20.03% compared to the previous year's $734,666. Losses were -$2.38 million, 45.3% more than in 2023.

Financial Statements

News

There is no news available yet.